首页> 外文OA文献 >Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer

【2h】

Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer

机译：表皮生长因子受体基因突变对日本非小细胞肺癌一线细胞毒性化疗后治疗结果的临床意义

页面导航

著录项
相似文献
相关主题

著录项

作者
Hotta Katsuyuki; Kiura Katsuyuki; Toyooka Shinichi; Takigawa Nagio; Soh Junichi; Fujiwara Yoshiro; Tabata Masahiro; Date Hiroshi; Tanimoto Mitsune;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations [J] . Lin Yen-Ting, Chen Jin-Shing, Liao Wei-Yu, International Journal of Cancer =: Journal International du Cancer . 2019,第11期

机译：临床结果和次生表皮生长因子受体（EGFR）T790M突变在一线吉非替尼，厄洛替尼和阿凡哚治疗的非小细胞肺癌患者的激活EGFR突变
2. Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [J] . Wen Gao, Jing He, Shi-Dai Jin, OncoTargets and therapy . 2019,第2期

机译：初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子抑制作用的抗T790M突变抗性抗性抗性抗肺癌患者的抗性抗性，抗血疱剂血管生长因子受体酪氨酸激酶激酶抑制剂
3. First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases [J] . Schuler Martin, Wu Yi-Long, Hirsh Vera, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2016,第3期

机译：一线Afatinib对非小细胞肺癌和常见表皮生长因子受体基因突变和脑转移的患者的化疗
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [O] . Wen Gao, Jing He, Shi-Dai Jin, 2019

机译：非小细胞肺癌患者对一线表皮生长因子受体酪氨酸激酶抑制剂耐药后初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子19缺失与T790M突变频率的关系
7. >Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [O] . Wen Gao, Jing He, Shi-Dai Jin, 2019

机译：>初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子抑制剂的抗血液抗性抗血液肺癌患者T790M突变抗性抗性后，抗抗血疱剂患者的抗性，抗抗血管生长因子受体酪氨酸激酶抑制剂

Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer

著录项

相似文献

相关主题

期刊订阅